Skip to main content

Interventional Endoscopy

Center for Interventional Endoscopy

Clinical Trials

Showing 1-9 out of 11 results.
NCT03926130

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease.

Icon for trial | I6T-MC-AMAM A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease.

This study is currently enrolling.

The main reason for you to take part in this study is not to treat you for your condition but to help in answering the following research questions: How safe mirikizumab is and whether you might have any side effects when you t ...

NCT03466411

A Phase 3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Subject with Moderately to Severely Active Crohn’s Disease

Icon for trial | CNTO1959CRD3001 A Phase 3, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Protocol to Evaluate the Efficacy and Safety of Guselkumab in Subject with Moderately to Severely Active Crohn’s Disease

This study is currently enrolling.

There are 3 separate studies being described in this form. All 3 studies have the same primary purposes, but there are some small differences between GALAXI 1 (which is a Phase 2 study) and GALAXI 2 & 3 (which are identical ...